Related Experiment Video
Updated: Aug 13, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Thrombophilia and pregnancy complications
1Klinische Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien.
Hamostaseologie
|January 31, 2006
Summary
Women with thrombophilia face higher risks of venous thromboembolism (VTE) during pregnancy. Early screening and treatment with low molecular weight heparin (LMWH) may reduce pregnancy loss in affected individuals.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Reproductive Medicine
Background:
- Venous thromboembolism (VTE) is a major cause of pregnancy complications.
- Thrombophilia significantly elevates the risk of VTE during pregnancy and the postpartum period.
- Previous VTE history further increases recurrent VTE risk in pregnant women.
Purpose of the Study:
- To review the association between thrombophilia and pregnancy complications, including VTE, pregnancy loss, and pre-eclampsia.
- To evaluate the current evidence on thrombophilia screening and management during pregnancy.
- To identify areas for future research in managing thrombophilia in pregnancy.
Main Methods:
- Literature review of studies on thrombophilia and pregnancy outcomes.
- Analysis of data from prospective studies and controlled trials.
- Synthesis of evidence regarding hereditary thrombophilia risk factors and their impact.
Main Results:
- Hereditary thrombophilia increases pregnancy-associated VTE risk (RR 3.4-15.2).
- Conflicting data exists on thrombophilia's link to pregnancy loss and pre-eclampsia.
- Low molecular weight heparin (LMWH) showed a positive effect in preventing pregnancy loss in one trial.
Conclusions:
- Thrombophilia screening may benefit women with a history of pregnancy loss.
- Consider LMWH for pregnant women with pregnancy loss and thrombophilia.
- Further research is crucial to establish optimal management strategies.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...